Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306877 · ClinicalTrials.gov registry record · NA
Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT01306877 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 149 participants.
The verdict
NCT01306877, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set for the treatment of hemorrhoids is non-inferior to the competitor device based on the primary endpoint.
Interventions
- DEVICE EEA Hemorrhoid and Prolapse Stapling Set
- DEVICE Endosurgery Proximate PPH03 Stapling Set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01306877
The ClinicalTrials.gov registry entry for NCT01306877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EEA Hemorrhoid and Prolapse Stapling Set is the first listed.
NCT01306877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01306877 about?
NCT01306877 is a clinical study titled "Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids". The purpose of this study is to demonstrate that the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set for the treatment of hemorrhoids is non-inferior to the competitor device based on the primary endpoint.
What is the current status of trial NCT01306877?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2011-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01306877?
The interventions under investigation include: EEA Hemorrhoid and Prolapse Stapling Set (DEVICE), Endosurgery Proximate PPH03 Stapling Set (DEVICE).
Who is sponsoring clinical trial NCT01306877?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.